← Back to All Filings
DexCom Director Nicholas Augustinos Sells $679.7K Under Rule 10b5-1 Plan
DEXCOM INC
$DXCM4CIK: 0001093557
Subscribe to track DXCM
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
📊 DexCom Inc ($DXCM) Insider Trade Alert
Insider: Nicholas Augustinos (Director) Action: Sold 8,089 shares of Common Stock (Indirect) Price: ~$84.04 per share Total Value: $679,768.56 Filing Date: 2026-09-16 Note: Executed under a pre-established Rule 10b5-1 plan adopted June 10, 2026.
Comprehensive Analysis
DexCom Inc ($DXCM) Form 4 Insider Filing Analysis
Executive Summary
- Reporting Owner: Nicholas Augustinos, Director
- Company: DexCom Inc ($DXCM)
- Filing Date: September 16, 2026
- Transaction Dates: September 14, 2026 and September 15, 2026
- Total Sale Value: $679,768.56 across 8,089 shares
Transaction Details
- 2026-09-14: Sold 1,550 shares indirectly (by Trust) at $84.02 per share ($130,231.00).
- 2026-09-15: Sold 6,539 shares indirectly (by Trust) at $84.04 per share ($549,537.56).
- Total Shares Disposed: 8,089 shares (Weighted Average Price: ~$84.04).
Post-Transaction Holdings
- Indirect Holdings (by Trust): 29,293 shares held by the Kirschner/Augustinos Revocable Trust.
- Direct Holdings: 5,575 unvested restricted stock units.
- Total Post-Transaction Ownership: 34,868 shares/RSUs.
Significance and Context
- Rule 10b5-1 Trading Plan: The sales were executed pursuant to a pre-arranged Rule 10b5-1 trading plan adopted on June 10, 2026.
- Significance Assessment: Low. Routine programmatic diversification under an established 10b5-1 trading plan by a non-executive director.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.